1. Home
  2. BMRA vs LGVN Comparison

BMRA vs LGVN Comparison

Compare BMRA & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$2.43

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$0.55

Market Cap

17.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMRA
LGVN
Founded
1971
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
17.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BMRA
LGVN
Price
$2.43
$0.55
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.50
AVG Volume (30 Days)
21.5K
408.1K
Earning Date
01-13-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,884,000.00
$1,437,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.08
$0.58
52 Week High
$10.16
$2.24

Technical Indicators

Market Signals
Indicator
BMRA
LGVN
Relative Strength Index (RSI) 44.61 31.82
Support Level $2.43 $0.58
Resistance Level $2.67 $0.65
Average True Range (ATR) 0.12 0.05
MACD 0.03 -0.00
Stochastic Oscillator 29.52 7.58

Price Performance

Historical Comparison
BMRA
LGVN

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: